FDA Stresses Stability Following Commissioner Crawford's Resignation
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS Secretary Leavitt praises Crawford and Acting Commissioner von Eschenbach while underscoring the experienced leadership remaining at the agency in a memo to FDA staff.
You may also be interested in...
FDA Cancels Series Of Town Hall Meetings Following Commissioner Crawford’s Resignation
The agency has no immediate plans to reschedule the public meetings, which were intended to help shape the agency’s agenda for 2006.
FDA Cancels Series Of Town Hall Meetings Following Commissioner Crawford’s Resignation
The agency has no immediate plans to reschedule the public meetings, which were intended to help shape the agency’s agenda for 2006.
Crawford Resigns; NCI Director Von Eschenbach Named To Top FDA Spot
Von Eschenbach appointed to be acting FDA commissioner following the Sept. 23 resignation of Lester Crawford.